#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Pleomorphic liposarcoma Oesophageal squamous cell carcinoma stage II Hypergammaglobulinaemia benign monoclonal Alveolar proteinosis Osteopetrosis Neurodermatitis Cholestatic pruritus Congenital myopathy Hypereosinophilic syndrome Ataxia telangiectasia Familial hypertriglyceridaemia Vascular malformation Immunodeficiency common variable Systemic lupus erythematosus Hereditary motor and sensory neuropathy More trials…

    Learn about Rare Diseases

    Factor VIII deficiency – Basic Information Fragile X syndrome – Life with Disease Factor VIII deficiency – Diagnostics Inclusion body myositis – Diagnostics Pemphigus – Diagnostics Extranodal marginal zone B-cell lymphoma (MALT type) Rhabdoid tumour – Life with Disease Langerhans’ cell histiocytosis – Treatment Leukoencephalopathy – Trials in Disease Haemophilia A without inhibitors – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Remestemcel Gr0015 Tiapride Resiniferatoxin Ulotaront Inotuzumab Ozogamicin Asparaginase L-ARGININE Spiramycin Doxorubicin Golexanolone TUVATEXIB Hct116-A ZOREVUNERSEN SODIUM VORMATRIGINE Mps-213 Elezanumab Afm24 Montelukast Sodium Abc-31-116 More therapies…

    Learn about Your Condition

    Neurodermatitis Transient ischaemic attack Medication overuse headache Inborn error of metabolism Anal cancer stage II Autoimmune haemolytic anaemia Anogenital warts Skin disorder Deafness Leukoencephalopathy Acquired ATTR amyloidosis Prader-Willi syndrome Mantle cell lymphoma stage IV Nocturia Obsessive-compulsive disorder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study Comparing Elranatamab and Lenalidomide with Daratumumab and Lenalidomide for Maintenance Therapy in Newly Diagnosed Multiple Myeloma Patients

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Elranatamab
    • Daratumumab
    • Lenalidomide
    France

  • Study of Gefurulimab for Children and Teens with Generalized Myasthenia Gravis

    Recruiting

    3 1 1
    Investigated Diseases:
    • Myasthenia gravis
    Investigated Drugs:
    • Gefurulimab
    Poland

  • Study on the Safety and Effectiveness of Short Dual Antiplatelet Therapy with Ticagrelor, Clopidogrel, and Prasugrel in Patients Aged 65+ with Coronary Artery Disease

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Chronic coronary syndrome
    Investigated Drugs:
    • D,L-Lysine Acetylsalicylate
    • Ticagrelor
    • Prasugrel
    France

  • Study of anti-seizure drug combination in comatose patients with status epilepticus after cardiac arrest

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Lacosamide
    • Lorazepam
    • Diazepam
    Belgium The Netherlands

  • Study on the Safety and Effectiveness of CRN04894 for Patients with Congenital Adrenal Hyperplasia

    Recruiting

    2 1 1
    Investigated Drugs:
    • ATUMELNANT
    Germany Italy

  • Study on Osimertinib and Chemotherapy for Stage IV Non-Small Cell Lung Cancer with Atypical EGFR Mutations

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Carboplatin
    • Cisplatin
    • Osimertinib
    Germany
Previous Page
1 … 237 238 239 240 241 … 1,649
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!